Evidence map›Paper›PMID 25427966›Full record

ArticleJournal of diabetes science and technology2015

A new metabolite panel test for identification of patients with impaired glucose tolerance? Analysis of the article by Cobb et al.

Andreas Pfützner

Open access · bronzeAbstract readComment
In one paragraph

Article in Journal of diabetes science and technology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Andreas PfütznerPfützner Science & Health Institute, Mainz, Germany andreas.pfuetzner@pfuetzner-mainz.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The article by Cobb et al represents solid research work applying the most sophisticated laboratory technologies, a very sound clinical research methodology, and valid statistical analysis procedures. The authors have identified a combination of metabolites suitable to replace the oral glucose tolerance test procedure in the identification of patients with impaired glucose tolerance (IGT) from a fasting blood draw. However, the discussed pathophysiological, clinical, and economic aspects may induce mechanisms restricting the probability of a global acceptance of this test for daily routine.

Indexed as

Insulin ResistanceBiomarkersBlood GlucoseDiabetes Mellitus, Type 2FemaleGlucose IntoleranceHumansMaleBiomarkersBlood Glucoseimpaired glucose toleranceIQ-IGT metabolite panelmetabolomicsoral glucose tolerance test

Identifiers

PMID25427966
PMCPMC4495538
OpenAlexW2010666172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.